替代补体成分B因子的酯酶活性研究 - Suppr | 超能文献

Studies on esterolytic activity of alternative complement component factor B.

作者信息

Ikari N, Hitomi Y, Niinobe M, Fujii S

出版信息

Biochim Biophys Acta. 1983 Jan 26;742(2):318-23. doi: 10.1016/0167-4838(83)90317-5.

DOI:10.1016/0167-4838(83)90317-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Studies on esterolytic activity of alternative complement component factor B.替代补体成分B因子的酯酶活性研究

Biochim Biophys Acta. 1983 Jan 26;742(2):318-23. doi: 10.1016/0167-4838(83)90317-5.

2

Interactions between the alternative complement pathway and proteases of the coagulation system.替代补体途径与凝血系统蛋白酶之间的相互作用。

Adv Exp Med Biol. 1984;167:235-9. doi: 10.1007/978-1-4615-9355-3_19.

3

An improved fluorogenic substrate for the alternative complement pathway C3/5 converting enzyme CVFBb.一种用于替代补体途径C3/5转化酶CVFBb的改进型荧光底物。

Biochim Biophys Acta. 1983 May 18;744(3):276-80. doi: 10.1016/0167-4838(83)90200-5.

4

Association of alternative complement pathway components with human blood platelets: secretion and localization of factor D and beta 1H Globulin.替代补体途径成分与人类血小板的关联：D因子和β1H球蛋白的分泌与定位

Clin Immunol Immunopathol. 1981 Dec;21(3):351-63. doi: 10.1016/0090-1229(81)90224-5.

5

Methylprednisolone inhibits the alternative and amplification pathways of complement.甲基泼尼松龙抑制补体的替代途径和扩增途径。

Infect Immun. 1982 Oct;38(1):122-6. doi: 10.1128/iai.38.1.122-126.1982.

6

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.一种用于定量检测人血清中替代补体途径激活的酶联免疫吸附测定法的开发与应用。

J Clin Invest. 1984 Jan;73(1):160-70. doi: 10.1172/JCI111187.

7

Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.克氏锥虫对替代补体途径的逃避源于B因子的低效结合。

Proc Natl Acad Sci U S A. 1986 Sep;83(17):6593-7. doi: 10.1073/pnas.83.17.6593.

8

Identification of a major serum DNA-binding protein as factor B of the alternative complement pathway.鉴定一种主要的血清DNA结合蛋白为替代补体途径的B因子。

J Immunol. 1980 Jun;124(6):2800-6.

9

Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.补体替代途径C3转化酶成分备解素与B因子之间相互作用的分析。

Biochem J. 1988 Aug 1;253(3):667-75. doi: 10.1042/bj2530667.

10

Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.人补体因子B：替代激活途径转化酶重组酶原的功能特性

Immunobiology. 1993 Jul;188(3):221-32. doi: 10.1016/S0171-2985(11)80231-7.

引用本文的文献

1

New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.胰凝乳蛋白酶折叠结构上的新基序及其在补体因子B中的潜在作用。

EMBO J. 2000 Jan 17;19(2):164-73. doi: 10.1093/emboj/19.2.164.

2

A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.补体激活的阻断通过调节大鼠黏膜肥大细胞脱颗粒来预防快速肠道缺血再灌注损伤。

Clin Exp Immunol. 1998 Mar;111(3):484-90. doi: 10.1046/j.1365-2249.1998.00518.x.

3

New synthetic inhibitor to the alternative complement pathway.新型替代补体途径合成抑制剂。

Immunology. 1983 Aug;49(4):685-91.